Bank Pembangunan Daerah Jawa Timur Tbk vs Merck Tbk. — how do they compare? Bank Pembangunan Daerah Jawa Timur Tbk trades at Rp515 (market cap 7.58T, 7.89M 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: Bank Pembangunan Daerah Jawa Timur Tbk is far larger — about 4.5× Merck Tbk.'s market cap, and Bank Pembangunan Daerah Jawa Timur Tbk is more actively traded (7.89M versus 22.8K). Which is the better fit depends on your goals.
| BJTM | MERK | |
|---|---|---|
Market Cap | 7.58T | 1.68T |
Volume | 7.89M | 22.8K |
Lot | 78.94K | 228 |
Turnover | 4.01B | 82.9M |
Average Price | 507.6 | 3,636.14 |
Value | 4.01B | 82.9M |
Indicative Equilibrium Price | 515 | 3,520 |
Indicative Equilibrium Volume | 280 | 60 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Pembangunan Daerah Jawa Timur Tbk (the Bank) was established under the name of PT Bank Pembangunan Daerah Djawa Timur dated August 17, 1961. The Bank started its commercial operations in accordance with the Decision Letter of the Minister of Finance of the Republic of Indonesia No. BUM 9-4-5 on August 15, 1961. The Sharia Operating Unit started its commercial operations on August 21, 2007 in accordance with the approval letter from Bank Indonesia No. 9/75/DS/Sb dated April 4, 2007 for the establishment of the Bank's Sharia Unit.
Read more on BJTM →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →